Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Quality of care for heart patients does not improve in first year of ACO participation

Researchers tracked patient outcomes through the use of 15 performance measures related to hypertension, coronary artery disease, heart failure and atrial fibrillation.

Video interview with Gregg Fonarow, MD, explaining the success of the AHA Get With The Guidelines-Stroke program, during AHA 2024.

American Heart Association program leads to substantial improvements in stroke care

Cardiologist Gregg Fonarow, MD, reviewed decades of data and discussed the long-term impact of the AHA's Get With The Guidelines-Stroke program.

hospital discharge planning AI artificial intelligence

5 ways AI can help a hospital’s discharge department

Among the myriad processes to which AI could be meaningfully applied in healthcare, perhaps few are more easily overlooked than discharging patients from the hospital. 

Thumbnail

FDA announces new recall of Medtronic surgical devices over safety concerns

The agency warned that any unused devices should be removed from the market and returned to the manufacturer.

Semaglutide, the GLP-1 receptor agonist sold by Novo Nordisk under the brand names Wegovy and Ozempic, is associated with significant health benefits for patients with type 2 diabetes and peripheral artery disease (PAD), according to a late-breaking clinical trial presented at ACC.25, the annual meeting of the American College of Cardiology (ACC).

‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes

Patients who present with type 2 diabetes and PAD often face substantial mobility issues. According to new data presented at ACC.25, however, treatment with semaglutide could represent a major step forward for this high-risk population.

betting big on AI artificial intelligence in healthcare

Healthcare AI newswatch: Great expectations for GenAI, disaster-ready AI, Dr. Oz on payer AI, more

Investors are betting on generative AI to solve costly provider workflow inefficiencies. So are provider executives. 

wearable health AI artificial intelligence

When health accessories grow up, they want to be wearable AI

Wearable health gadgets equipped with AI present myriad opportunities and challenges to healthcare consumers and the healthcare professionals who diagnose, treat and track them.